GLOBEALERT
HEALTHLOW2h ago · Sep 23, 2026, 5:50 PM

AstraZeneca granted EU label expansion for COPD therapy, Trixeo in asthma

Seeking Alpha Tech · western europe

AstraZeneca has been granted an EU label expansion for its COPD therapy and for Trixeo in asthma. This indicates an expansion of approved uses for these pharmaceutical products within the European Union.

GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.

More in Health